The global malaria vaccines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The occurrence of malaria in tropical countries has been tough globally, contributing to millions of mortalities over the last ten years. The development of vaccines forms a vital part of adequate interventional control. Recent years have seen considerable research on novel vaccine candidates. Supported by continuous research of malaria life-cycle, a diverse pipeline has been investigated. Understanding the biology of lethal human malaria parasites, Plasmodium falciparum and Plasmodium vivax is key to developing avenues within the market. Generations of pre-erythrocytic vaccines have unlocked new possibilities in the market. This has attracted several investments from biotech agencies. This is a factor that is expected to fuel the market growth during the forecast period. Over the past couple of years, researchers have been able to boom the vaccine-induced efficacy substantially.
To Request a Sample of our Report on Global Malaria Vaccines Market: https://www.omrglobal.com/request-sample/malaria-vaccines-market
The spate of medical trials has targeted enhancing RTS, S/AS01. Such tendencies were invigorated by the latest trials in sub-Saharan Africa. According to the WHO, RTS,S has been evaluated to be used as a complementary malaria control tool to its preventive, diagnostic, as well as treatment measures. It is the only vaccine that has demonstrated its efficacy in reducing malaria, especially in younger African children. The growing number of routine immunization programs in various countries is boosting the market. Over the past few years, the World Health Organisation (WHO) has made coordinated efforts to promote public health by using the vaccine. The advent of novel adjuvants and cutting-edge vaccine delivery platforms are opening new avenues in the market. Another factor that is boosting the market growth includes the growing range of routine immunization programs in various countries.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: GlaxoSmithKline plc, Sanaria Inc., and Sumaya Biotech, among others.
(Get 15% Discount on Buying this Report)
A full Report of Global Malaria Vaccines Market is Available at: https://www.omrglobal.com/industry-reports/malaria-vaccines-market
Global Malaria Vaccines Market Report by Segment
By Agent Type
• Plasmodium Falciparum
• Plasmodium Vivax
• Anopheles Species
By Vaccine Type
• Pre-Erythrocytic Vaccine
• Erythrocytic Vaccine
• Multi-antigen Vaccine
By Distribution Channel
• Hospitals
• Clinics
• Community Centers
Global Malaria Vaccines Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
